Cytek Biosciences, Inc. CTKB NASDAQ

NASDAQ Global Select • Healthcare • Medical - Devices • US • USD

SharesGrow Score

50/100

2/7 Pass

SharesGrow Intrinsic Value

Cytek Biosciences, Inc. (CTKB) 报告总资产为 $461.54M 总负债为 $119.8M 財年 2025, 总权益为 $341.74M.

公司持有 $261.53M 现金及短期投资. 总债务为 $33.02M, 净债务为 $-57.83M. D/E比率为 0.1 (保守的).

流动比率为 5.04, 表明短期流动性强. 利息覆蓋率为 -85.2x (weak).

本页支持的标准:

HEALTH (67/100, Partial) — 部分指标尚可但未全部达到理想水准
MOAT (49/100) — 总资产 $461.54M 和 equity $341.74M 支持公司的竞争规模
VALUE (92/100) — Debt-to-Equity 0.1 影响整体估值风险评估

SharesGrow 收入评分: 50/100 其中 2/7 项标准通过.

SharesGrow 7-Criteria Score

50/100

SG Score

View full scorecard →

✓

价值

92/100

Price-to-Earnings & upside

→ Valuation

✓

未來

67/100

Analyst consensus

→ Forecast

✗

过去

25/100

→ Income

健康

67/100

Debt-to-Equity & liquidity

Proven by this page

护城河

49/100

→ Income

成长

40/100

→ Income

✗

收入

10/100

→ Income

Cytek Biosciences, Inc. 资产负债表历史

指标	FY2025	FY2024	FY2023	FY2022
总资产	$461.54M	$499.5M	$494.46M	$519.48M
Total Liabilities	$119.8M	$103.76M	$101.39M	$93.93M
总债务	$33.02M	$17.02M	$14.14M	$18.09M
Cash & Investments	$261.53M	$277.86M	$262.41M	$341.15M
股东权益总计	$341.74M	$395.74M	$393.06M	$425.3M